Yeah, i feel for those who stayed in. I had 1500 shares i sold 3 days ago of clsn. Like i said in a previous post, i got a real uneasy feeling when they posted the china deal ahead of the p3 results. Something there told me the results were gonna be a mixed bag. Got out at 8.06... I am so glad i did. I feel for the clsn longs as being a dcth investor i know the pain. On another note i hope this brings in a catalyst and a now china deal being that dcth seems to have weathered the storm and is sitting in a good spot. I also wonder what draw back wil this clsn p3 have on fda approval. With results this bad i cant see how fda will give them the nod
This also strengthens DCTH's negotiating position with an ASIA partner. It looks like HOBBS knows what he is doing. Once DCTH get's FDA approval they will be able to get stronger terms on the partnership. DCTH has leverage!
The irony of CLSN and DCTH both trading at 1.55 in pre-market is beyond interesting. Hopefully, with opposing trend lines. Been through 2 big crashes with DCTH so I'm not going to taunt CLSN holders. The sickening feeling they have this morning is enough.